U.S. Covid response may have to be scaled back because of congressional funding inaction- White House
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Pfizer announced Wednesday that it has started a clinical trial testing its Covid-19 antiviral pill in children as young as 6.
The drugmaker said it aims to enroll approximately 140 participants in the trial, which will look at whether the drug, called Paxlovid, can safely treat Covid in children who are at risk of becoming severely ill. ...
Submitted by mike kraft on
WASHINGTON — The Biden administration on Tuesday formally began allowing Americans who had ordered free coronavirus tests this winter to request a second round of four tests per household, through the same U.S. Postal Service program that President Biden unveiled in January.
The move, which Mr. Biden had promised last week during his State of the Union address, followed a crush of interest in the program when it debuted in January. At the time, case rates had skyrocketed because of the Omicron variant and tens of millions of households scrambled to obtain the free tests.
Submitted by FNUOvviyaa on
Submitted by FNUOvviyaa on
Nearly all local and systemic adverse events (AEs) reported after Pfizer or Moderna's COVID-19 vaccines were mild and transient, and only a fraction of individuals reported seeking medical care, according to data from the Vaccine Adverse Event Reporting System (VAERS) and CDC's v-safe tracker.
Submitted by mike kraft on
Submitted by mike kraft on
Almost two years after the director of the Centers for Disease Control and Prevention called for 100,000 contact tracers to contain the coronavirus, the C.D.C. said this week that it no longer recommends universal case investigation and contact tracing. Instead it encourages health departments to focus those practices on high-risk settings.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on